Related Experiment Video
Updated: Jul 16, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
[Dimorphism and pathogenesis of Histoplasma capsulatum]
1Centro de Referencia de Micologia, Facultad de Ciencias Bioquimicas y Farmacdutica, Universidad Nacional de Rosario, Suipacha 531 (2000) Rosario, Argentina. clopez@fbioyf.unr.edu.ar
Abstract:
Dimorphism and pathogenesis of Hisdistoplasma capsulatum is a dimorphic fungal pathogen with worldwide significance, which causes a broad spectrum of disease. In the saprophytic stage, it lives as a mycelial form consisting of hyphae bearing both macro and microconidia. Infection with H. capsulatum occurs by inhalation of microconidia (1-4 x 2-6 microm) or small mycelia fragments (5-8 microm) in the terminal bronchioles and alveoli of the lung. Inhaled conidia then convert into the yeast form that is responsible for the pathogenesis of histoplasmosis. As a soil fungus with no known requirements for interacting with a mammalian host as a necessary stage of its life cycle, the number of its strategies for successful pathogenesis is particularly remarkable. They include dimorphic mould-yeast transition, entry into host macrophages, subcellular localization, intracellular survival and proliferation during clinically unapparent infection with capacity for reactivation. H. capsulatum became the subject of increasing studies concurrently with the rising prevalence of human immunodeficiency. This paper presents an overall view of advances in the investigation of H. capsulatum dimorphic transition and pathogenesis.
More Related Videos
Related Concept Videos
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Diversity of Protists II
Fungal Group Zygomycota
Fungal Phylum Basidiomycota
Malaria

